Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alström Syndrome

Elsevier

Available online 6 April 2024, 101933

Molecular MetabolismAuthor links open overlay panel, , , , , , , , Highlights•

We tested whether lipotoxic insulin resistance in Alström Syndrome (AS) is due to adipose “failure”.

Alms1 KO in mesenchymal stem cells recapitulated insulin resistance, adipose hypertrophy and fatty liver.

Surprisingly, hyperphagia was seen in females with neurone-sparing, MSC-specific Alms1 KO.

Our findings support a key role for constrained adipose expansion in metabolic complications of AS.

Oligodendrocyte precursor cells may play a role in the hyperphagic obesity of AS.

AbstractObjective

Alström Syndrome (AS), caused by biallelic ALMS1 mutations, includes obesity with disproportionately severe insulin resistant diabetes, dyslipidemia, and fatty liver. Prior studies suggest that hyperphagia is accounted for by loss of ALMS1 function in hypothalamic neurones, whereas disproportionate metabolic complications may be due to impaired adipose tissue expandability. We tested this by comparing the metabolic effects of global and mesenchymal stem cell (MSC)-specific Alms1 knockout.

Methods

Global Alms1 knockout (KO) mice were generated by crossing floxed Alms1 and CAG-Cre mice. A Pdgfrα-Cre driver was used to abrogate Alms1 function selectively in MSCs and their descendants, including preadipocytes. We combined metabolic phenotyping of global and Pdgfrα+ Alms1-KO mice on a 45% fat diet with measurements of body composition and food intake, and histological analysis of metabolic tissues.

Results

Assessed on 45% fat diet to promote adipose expansion, global Alms1 KO caused hyperphagia, obesity, insulin resistance, dyslipidaemia, and fatty liver. Pdgfrα-cre driven KO of Alms1 (MSC KO) recapitulated insulin resistance, fatty liver, and dyslipidaemia in both sexes. Other phenotypes were sexually dimorphic: increased fat mass was only present in female Alms1 MSC KO mice. Hyperphagia was not evident in male Alms1 MSC KO mice, but was found in MSC KO females, despite no neuronal Pdgfrα expression.

Conclusions

Mesenchymal deletion of Alms1 recapitulates metabolic features of AS, including fatty liver. This confirms a key role for Alms1 in the adipose lineage, where its loss is sufficient to cause systemic metabolic effects and damage to remote organs. Hyperphagia in females may depend on Alms1 deficiency in oligodendrocyte precursor cells rather than neurones. AS should be regarded as a forme fruste of lipodystrophy.

Keywords

Alms1

Alström syndrome

insulin resistance

diabetes

adipose tissue

mouse

© 2024 Published by Elsevier GmbH.

留言 (0)

沒有登入
gif